Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 552)
Posted On: 01/09/2020 4:30:34 PM
Post# of 154120
Posted By: generactor
Re: docj #14662
NASH comment in 10Q


Says, "leronlimab may control the devastating effects of liver fibrosis". It's still unclear to me whether leronlimab has the potential to reverse fibrosis or not.

We've discussed this in the past and I believe it was trding who pointed to a Nader quote along those lines but it's still something I would like Nader to explicitly address. Reversing fibrosis is a big goal of NASH drugs and whether or not leronlimab can do that will likely be a large factor in how big the drug's impact can be in the NASH space.













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site